Table 2:
Dust OPEs and RBFRs and urinary OPEs in pregnant mothers overall and by children’s characteristics – HOME Study (N = 342)
| Characteristics | % | Dust Flame-Retardant Concentrations (μg/g dust) | Urinary OPEs adjusted for specific gravity | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPEs | RBFRs | ||||||||||
| TCEP | TCIPP | TDCIPP | TPHP | EH-TBB | BEH-TEBP | BCEP | BCIPP | BDCIPP | DPHP | ||
| Child’s sex | |||||||||||
| Female | 55.3 | 0.65 (0.08) | 2.03 (0.22) | 1.81 (0.19) | 1.38 (0.13) | 0.06 (0.01) | 0.13 (0.01) | 0.72 (0.07) | 0.10 (0.01) | 1.09 (0.09) | 1.79 (0.12) |
| Male | 44.7 | 0.67 (0.09) | 2.17 (0.28) | 1.65 (0.18) | 1.12 (0.12) | 0.06 (0.01) | 0.13 (0.01) | 0.72 (0.07) | 0.11 (0.01) | 0.99 (0.09) | 1.79 (0.14) |
| Race/ethnicity | |||||||||||
| NH-White | 64.3 | 0.80 (0.09) | 2.65 (0.28) | 1.94 (0.19) | 1.28 (0.12) | 0.07 (0.01) | 0.17 (0.01) | 0.60 (0.05) | 0.11 (0.01) | 0.99 (0.08) | 1.68 (0.11) |
| NH-Black | 28.9 | 0.41 (0.06) | 1.41 (0.20) | 1.38 (0.19) | 1.20 (0.16) | 0.05 (0.01) | 0.08 (0.01) | 1.03 (0.14) | 0.10 (0.004) | 1.17 (0.14) | 2.08 (0.17) |
| Hispanic/Othera | 6.7 | 0.91 (0.34) | 1.47 (0.38) | 1.71 (0.48) | 1.29 (0.43) | 0.05 (0.01) | 0.10 (0.03) | 1.13 (0.34) | 0.10 (0.01) | 1.05 (0.22) | 1.95 (0.37) |
| Term | |||||||||||
| Preterm | 9.4 | 0.46 (0.12) | 1.64 (0.34) | 2.03 (0.36) | 1.41 (0.30) | 0.07 (0.01) | 0.14 (0.02) | 0.50 (0.10) | 0.12 (0.02) | 1.13 (0.25) | 1.71 (0.27) |
| Normal term | 90.6 | 0.68 (0.07) | 2.15 (0.19) | 1.71 (0.14) | 1.24 (0.10) | 0.06 (0.01) | 0.13 (0.01) | 0.74 (0.06) | 0.10 (0.004) | 1.03 (0.07) | 1.80 (0.09) |
| Birth weight | |||||||||||
| Low | 5.6 | 0.52 (0.17) | 1.55 (0.42) | 2.46 (0.66) | 2.19 (0.69) | 0.11 (0.03) | 0.18 (0.04) | 0.77 (0.20) | 0.10 (0.01) | 1.24 (0.33) | 1.98 (0.47) |
| Normal | 79.5 | 0.69 (0.07) | 2.23 (0.21) | 1.73 (0.15) | 1.16 (0.09) | 0.05 (0.01) | 0.12 (0.01) | 0.66 (0.05) | 0.11 (0.01) | 1.01 (0.07) | 1.70 (0.09) |
| High | 14.9 | 0.52 (0.15) | 1.66 (0.36) | 1.51 (0.32) | 1.57 (0.34) | 0.07 (0.02) | 0.15 (0.03) | 1.10 (0.20) | 0.10 (0.01) | 1.14 (0.16) | 2.25 (0.26) |
| Household income | |||||||||||
| <$50,000 | 43.6 | 0.51 (0.07) | 1.73 (0.23) | 1.67 (0.22) | 1.19 (0.13) | 0.05 (0.01) | 0.11 (0.01) | 1.01 (0.10) | 0.10 (0.005) | 1.09 (0.10) | 2.10 (0.16) |
| $50,000 to $74,999 | 16.9 | 0.74 (0.15) | 2.41 (0.38) | 1.85 (0.29) | 1.43 (0.26) | 0.06 (0.01) | 0.14 (0.02) | 0.76 (0.13) | 0.11 (0.01) | 1.10 (0.13) | 1.59 (0.18) |
| $75,000+ | 39.5 | 0.83 (0.13) | 2.44 (0.31) | 1.76 (0.19) | 1.26 (0.14) | 0.06 (0.01) | 0.15 (0.02) | 0.51 (0.05) | 0.11 (0.01) | 0.97 (0.10) | 1.62 (0.13) |
| Breastfed | |||||||||||
| No | 17.0 | 0.64 (0.14) | 1.54 (0.29) | 1.56 (0.31) | 0.98 (0.19) | 0.05 (0.01) | 0.08 (0.01) | 0.73 (0.13) | 0.09 (0.005) | 1.30 (0.21) | 2.41 (0.30) |
| Yes | 83.0 | 0.66 (0.07) | 2.23 (0.20) | 1.78 (0.15) | 1.32 (0.10) | 0.06 (0.01) | 0.14 (0.01) | 0.72 (0.11) | 0.11 (0.01) | 0.99 (0.06) | 1.69 (0.09) |
| Serum cotinine (ng/mL) | |||||||||||
| < 0.10 | 68.1 | 0.70 (0.08) | 2.28 (0.21) | 1.78 (0.16) | 1.27 (0.11) | 0.07 (0.01) | 0.15 (0.01) | 0.63 (0.05) | 0.11 (0.01) | 1.02 (0.07) | 1.64 (0.10) |
| 0.10 to 10 | 23.4 | 0.62 (0.12) | 1.97 (0.39) | 1.71 (0.29) | 1.27 (0.19) | 0.05 (0.01) | 0.10 (0.01) | 0.94 (0.14) | 0.11 (0.01) | 1.04 (0.13) | 2.18 (0.21) |
| > 10 | 8.5 | 0.44 (0.13) | 1.22 (0.34) | 1.50 (0.42) | 1.09 (0.26) | 0.04 (0.01) | 0.09 (0.02) | 1.08 (0.25) | 0.09 (0.005) | 1.20 (0.26) | 2.29 (0.34) |
Abbreviation: NH: Non-Hispanic; TCEP: tris(2-chloroethyl) phosphate, TCIPP: tris(1-chloro-2-propyl) phosphate, TDCIPP: tris(1,3-dichloroisopropyl) phosphate, TPHP: triphenyl phosphate, EH-TBB: 2-ethylhexyl-2,3,4,5-tetrabromobenzoate, BEH-TBP: bis(2-ethylhexyl) tetrabromophthalate; BCEP: bis-2-chloroethyl phosphate, BCIPP: bis(1-chloro-2-propyl) phosphate, BDCIPP: bis(1,3-dichloro-2-propyl) phosphate, DPHP: diphenyl phosphate.
‘Other’ race/ethnicity included Native Hawaiian or Other Pacific Islander or Asian participants
Bold indicates significant difference in dust flame retardant concentrations or loadings across participants’ characteristics.